Pharmacometrics consulting services

Way of working

Benefits

Use model-based predictions in internal decision making and regulatory filings

Thanks to Pharmetheus long experience in supporting MIDD plans for the pharmaceutical industry, our QSP platform is in a privileged position to rapidly identify with its client’s situation and help them extract maximum value from QSP, without the need to commit to expensive, heavy-weight and closed licensed tools.

This approach also gives us the agility to evolve our QSP models with our client’s needs, or to integrate our simulations with emerging innovative approaches, such as machine learning analyses or generative AI.

A top down pharmacometric approach to the analysis of clinical trial data enables:

A description of the absorption, distribution and elimination of drugs in the body.
Linking drug concentration or exposure to biomarker, efficacy or safety responses.
A quantification of the temporal characteristics of drug response.
Simulation of the outcome of future clinical trials.
Prediction of situations outside the context studies in the clinical trials.
Characterization of the expected exposure and response in patient subgroups of interest.